Efficacy and Tolerability of Nintedanib in Idiopathic-Inflammatory-Myopathy-Related Interstitial Lung Disease: A Pilot Study

Frontiers in Medicine

Junyu Liang¹  Lihuan Yue¹  Yang Yang¹  Ye Yu¹  Heng Cao¹  Chuanyin Sun¹  Yini Ke¹  Jin Lin² 

[1] Department of Rheumatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China;orcid.org/0000-0002-0978-0723;

关键词: nintedanib;    interstitial lung disease;    dermatomyositis;    polymyositis;    anti-MDA5 antibody;   

DOI  :  10.3389/fmed.2021.626953

来源: Frontiers

【 授权许可】

CC BY